Brief: Crispr Therapeutics May Offer & Sell Common Shares Of Up To $600 Million From Time To Time
15/10/2025 22:50
CRISPR Therapeutics AG CRSP.BN: CRISPR THERAPEUTICS: MAY OFFER & SELL COMMON SHARES OF UP TO $600 MILLION FROM TIME TO TIME Source text: [ID:n0001193125-25-240259] Further company coverage: CRSP.BN
Recent news on Crispr Therapeutics AG
See all newsBrief: CRISPR Therapeutics Announces Chief Financial Officer Transition
Swiss stocks - Factors to watch on August 4
Switzerland's CRISPR Therapeutics Q2 CASGEVY revenue jumps 151%, net loss narrows on FDA approval for expansion
Swiss stocks - Factors to watch on August 3
Gene-editing firm CRISPR steadies after boosted $550 mln convertible debt deal